ArticleJournal of Cancer2022

Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma.

Hong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.